Purchase Order 75N91018P00392

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. valued at $21,581.00 on August 28, 2018, with completion scheduled for September 28, 2018. Performance occurs at Bethesda, Maryland. The order is firm fixed price with no small business set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. for $5,850.00 on March 15, 2018, with ultimate completion on April 13, 2018. The order covers laboratory supplies under firm fixed price terms. Place of performance is Pleasanton, California.</p>

<p>The National Cancer Institute issued a purchase order to 10X Genomics, Inc. for $22,366.00 in lab supplies, awarded August 15, 2017, with completion by September 13, 2017. Performance occurs at 10X Genomics' facility in Pleasanton, California. The order is firm fixed price with no set-aside category.</p>

<p>The National Cancer Institute issued a purchase order to 10X Genomics, Inc., for $5,850 on April 26, 2018, to supply laboratory reagents and genomic analysis consumables. Performance occurs at 10X Genomics' facility in Pleasanton, California, with ultimate completion by May 25, 2018. The order is priced on a firm fixed price basis with no small business set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. for $5,554.00 on August 22, 2017, with a completion date of September 21, 2017. The order covers laboratory supplies, with place of performance in Pleasanton, California. Pricing is firm fixed price under a no-set-aside simplified acquisition.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. for $5,660.00 on June 27, 2017, for laboratory supplies. Performance occurs in Pleasanton, California, with an ultimate completion date of July 21, 2017. The order covers 10X Genomics single-cell and spatial transcriptomics reagents and consumables supplied under firm fixed price, with no small business set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. valued at $5,600 on November 16, 2017, for laboratory supplies. Performance location is Pleasanton, California. The order carries a firm fixed price and ultimate completion date of December 31, 2017.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. for $5,850.00 on May 30, 2018, for lab supplies. Performance occurs at the vendor's facility in Pleasanton, California. The order carries a firm fixed price and is scheduled for completion by June 28, 2018.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. valued at $10,718.00 on June 25, 2020, with completion scheduled for July 24, 2020. Performance takes place in Pleasanton, California. The order is firm fixed price with no set-aside designation. The source does not specify the items or services being procured.</p>

<p>The National Cancer Institute awarded a purchase order to 10X Genomics, Inc. for lab supplies valued at $5,847.00 on January 4, 2018, with completion targeted for February 2, 2018. Performance occurs in Pleasanton, California. The order is firm fixed price with no small business set-aside.</p>